BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 30467700)

  • 21. Distinguishing Benign Renal Tumors with an Oncocytic Gene Expression (ONEX) Classifier.
    McGillivray PD; Ueno D; Pooli A; Mendhiratta N; Syed JS; Nguyen KA; Schulam PG; Humphrey PA; Adeniran AJ; Boutros PC; Shuch B
    Eur Urol; 2021 Jan; 79(1):107-111. PubMed ID: 32972793
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Claudin-7 and claudin-8: immunohistochemical markers for the differential diagnosis of chromophobe renal cell carcinoma and renal oncocytoma.
    Osunkoya AO; Cohen C; Lawson D; Picken MM; Amin MB; Young AN
    Hum Pathol; 2009 Feb; 40(2):206-10. PubMed ID: 18799195
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Diagnostic utility of S100A1, GLUT-1 and Caveolin-1 in renal tumors with oncocytic features: a comparative study].
    Zhang W; Wang K; Yu W; Liu Y; Chu J; Jiang Y; Li Y
    Zhonghua Bing Li Xue Za Zhi; 2015 Nov; 44(11):767-71. PubMed ID: 26888385
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Genomic expression and single-nucleotide polymorphism profiling discriminates chromophobe renal cell carcinoma and oncocytoma.
    Tan MH; Wong CF; Tan HL; Yang XJ; Ditlev J; Matsuda D; Khoo SK; Sugimura J; Fujioka T; Furge KA; Kort E; Giraud S; Ferlicot S; Vielh P; Amsellem-Ouazana D; Debré B; Flam T; Thiounn N; Zerbib M; Benoît G; Droupy S; Molinié V; Vieillefond A; Tan PH; Richard S; Teh BT
    BMC Cancer; 2010 May; 10():196. PubMed ID: 20462447
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Immunohistochemical stain for cytokeratin 7, S100A1 and claudin 8 is valuable in differential diagnosis of chromophobe renal cell carcinoma from renal oncocytoma.
    Kim SS; Choi YD; Jin XM; Cho YM; Jang JJ; Juhng SW; Choi C
    Histopathology; 2009 Apr; 54(5):633-5. PubMed ID: 19302533
    [No Abstract]   [Full Text] [Related]  

  • 26. Role of carbonic anhydrase IX, α-methylacyl coenzyme a racemase, cytokeratin 7, and galectin-3 in the evaluation of renal neoplasms: a tissue microarray immunohistochemical study.
    Bing Z; Lal P; Lu S; Ziober A; Tomaszewski JE
    Ann Diagn Pathol; 2013 Feb; 17(1):58-62. PubMed ID: 22898056
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Decreased Mitochondrial DNA Content Drives OXPHOS Dysregulation in Chromophobe Renal Cell Carcinoma.
    Xiao Y; Clima R; Busch J; Rabien A; Kilic E; Villegas SL; Timmermann B; Attimonelli M; Jung K; Meierhofer D
    Cancer Res; 2020 Sep; 80(18):3830-3840. PubMed ID: 32694149
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Exploring Multiphoton Microscopy as a Novel Tool to Differentiate Chromophobe Renal Cell Carcinoma From Oncocytoma in Fixed Tissue Sections.
    Jain M; Robinson BD; Wu B; Khani F; Mukherjee S
    Arch Pathol Lab Med; 2018 Mar; 142(3):383-390. PubMed ID: 29219617
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Oncocytoma versus chromophobe renal cell carcinoma: Is there something in between?].
    Lüders C; Kristiansen G
    Pathologe; 2016 Mar; 37(2):153-8. PubMed ID: 26925847
    [TBL] [Abstract][Full Text] [Related]  

  • 30. FOXI1 expression in chromophobe renal cell carcinoma and renal oncocytoma: a study of The Cancer Genome Atlas transcriptome-based outlier mining and immunohistochemistry.
    Tong K; Hu Z
    Virchows Arch; 2021 Apr; 478(4):647-658. PubMed ID: 32812119
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Identification and Validation of Radiographic Enhancement for Reliable Differentiation of CD117(+) Benign Renal Oncocytoma and Chromophobe Renal Cell Carcinoma.
    Amin J; Xu B; Badkhshan S; Creighton TT; Abbotoy D; Murekeyisoni C; Attwood KM; Schwaab T; Hendler C; Petroziello M; Roche CL; Kauffman EC
    Clin Cancer Res; 2018 Aug; 24(16):3898-3907. PubMed ID: 29752278
    [No Abstract]   [Full Text] [Related]  

  • 32. Immunohistochemical analysis of chromophobe renal cell carcinoma, renal oncocytoma, and clear cell carcinoma: an optimal and practical panel for differential diagnosis.
    Liu L; Qian J; Singh H; Meiers I; Zhou X; Bostwick DG
    Arch Pathol Lab Med; 2007 Aug; 131(8):1290-7. PubMed ID: 17683191
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Morphological, immunohistochemical, and chromosomal analysis of multicystic chromophobe renal cell carcinoma, an architecturally unusual challenging variant.
    Foix MP; Dunatov A; Martinek P; Mundó EC; Suster S; Sperga M; Lopez JI; Ulamec M; Bulimbasic S; Montiel DP; Alaghehbandan R; Peckova K; Pivovarcikova K; Ondrej D; Rotterova P; Skenderi F; Prochazkova K; Dusek M; Hora M; Michal M; Hes O
    Virchows Arch; 2016 Dec; 469(6):669-678. PubMed ID: 27631338
    [TBL] [Abstract][Full Text] [Related]  

  • 34. TGF-β1 expression in chromophobe renal cell carcinoma and renal oncocytoma.
    Demirović A; Cesarec S; Marušić Z; Tomas D; Milošević M; Hudolin T; Krušlin B
    Eur J Histochem; 2014 Jan; 58(1):2265. PubMed ID: 24704995
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Claudin-7 is highly expressed in chromophobe renal cell carcinoma and renal oncocytoma.
    Choi YD; Kim KS; Ryu S; Park Y; Cho NH; Rha SH; Jang JJ; Ro JY; Juhng SW; Choi C
    J Korean Med Sci; 2007 Apr; 22(2):305-10. PubMed ID: 17449941
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Diagnostic value of cytokeratin 7 and parvalbumin in differentiating chromophobe renal cell carcinoma from renal oncocytoma.
    Adley BP; Papavero V; Sugimura J; Teh BT; Yang XJ
    Anal Quant Cytol Histol; 2006 Aug; 28(4):228-36. PubMed ID: 16927643
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Clinicopathological features of hybrid oncocytic/chromophobe renal cell tumor].
    Wang Y; Chong DC; Xin FJ; He B; Liu XL; Li YJ; Zhang W; Jiang YX
    Zhonghua Bing Li Xue Za Zhi; 2021 Feb; 50(2):97-102. PubMed ID: 33535302
    [No Abstract]   [Full Text] [Related]  

  • 38. Diagnostic accuracy for hybrid oncocytic/chromophobe renal cell tumors by exploiting an immunohistochemical and histochemical combined panel.
    Roncati L; Barbolini G; Maiorana A
    Diagnosis (Berl); 2017 Jun; 4(2):109-110. PubMed ID: 29536916
    [No Abstract]   [Full Text] [Related]  

  • 39. Progesterone receptor reactivity in renal oncocytoma and chromophobe renal cell carcinoma.
    Mai KT; Teo I; Belanger EC; Robertson SJ; Marginean EC; Islam S
    Histopathology; 2008 Feb; 52(3):277-82. PubMed ID: 18081814
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Expression of kidney-specific cadherin distinguishes chromophobe renal cell carcinoma from renal oncocytoma.
    Mazal PR; Exner M; Haitel A; Krieger S; Thomson RB; Aronson PS; Susani M
    Hum Pathol; 2005 Jan; 36(1):22-8. PubMed ID: 15712178
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.